Medication adherence in patients with schizophrenia

被引:72
|
作者
Phan, Stephanie V. [1 ]
机构
[1] Univ Georgia, Coll Pharm, Southwest Georgia Clin Campus,1000 Jefferson St, Albany, GA 31701 USA
来源
关键词
schizophrenia; antipsychotics; medication compliance; nonadherence; RANDOMIZED CONTROLLED-TRIAL; ANTIPSYCHOTIC MEDICATION; IMPROVE ADHERENCE;
D O I
10.1177/0091217416636601
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Medication nonadherence is common among patients with schizophrenia and due to a variety of factors including lack of insight, psychopathology, substance use disorder, issues associated with treatment, stigma, fragmentation of care, cultural influences, and socioeconomic status. Among this population, nonadherence is problematic because it can lead to decompensation or exacerbation of symptoms, relapse, rehospitalization or greater use of emergency psychiatric services, functional decline, and increased risk of death. Psychoeducational approaches alone are ineffective, but in combination with behavioral interventions, appear to be effective. Involving the patient's support system, in addition to other interventions, can improve treatment adherence. Many medication-related factors, such as effectiveness and tolerability of antipsychotics, regimen complexity, and past medication trials impact appropriate medication use. Therefore, optimizing the patient's pharmacotherapeutic regimens can improve adherence. Additional factors favorably influencing adherence include involving the patient in their treatment, fostering a therapeutic alliance, implementing/using reminder systems, and addressing substance use disorder. Medication nonadherence arises from multiple reasons that vary between patients. Thus, the most effective strategies to improve adherence are multifactorial and may involve both psychoeducational and behavioral techniques, as well as previously listed approaches. Strategies should be targeted toward the patient and their support system, whenever possible, to further improve the chances of appropriate medication use. Recognizing that all patients with schizophrenia are at risk for medication nonadherence is important. No one technique has been shown to be most effective; therefore, the risk for nonadherence should continually be assessed and multiple strategies should be targeted to the patient (and caregiver) and repeatedly implemented throughout the course of the patient's illness.
引用
收藏
页码:211 / 219
页数:9
相关论文
共 50 条
  • [21] Medication adherence in schizophrenia: Exploring patients', carers' and professionals' views
    Kikkert, Martijn J.
    Schene, Aart H.
    Koeter, Maarten W. J.
    Robson, Debbie
    Born, Anja
    Helm, Hedda
    Nose, Michela
    Goss, Claudia
    Thornicroft, Graham
    Gray, Richard J.
    [J]. SCHIZOPHRENIA BULLETIN, 2006, 32 (04) : 786 - 794
  • [22] Survey of medication adherence in patients with schizophrenia - Korean ADHES data
    Kim, Sung-Wan
    Yoon, Jin-Sang
    Choi, Sung-Ku
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2006, 21 (08) : 533 - 537
  • [23] Medication Adherence and Hospitalization Among Patients With Schizophrenia Treated With Antipsychotics
    Lang, Kathleen
    Meyers, Juliana L.
    Korn, Jonathan R.
    Lee, Seina
    Sikirica, Mirko
    Crivera, Concetta
    Dirani, Riad
    Menzin, Joseph
    [J]. PSYCHIATRIC SERVICES, 2010, 61 (12) : 1239 - 1247
  • [24] Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review
    Hegedues, Anna
    Kozel, Bernd
    [J]. INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2014, 23 (06) : 490 - 497
  • [25] Interventions to improve medication adherence in schizophrenia
    Zygmunt, A
    Olfson, M
    Boyer, CA
    Mechanic, D
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (10): : 1653 - 1664
  • [26] Schizophrenia and medication adherence: Associated factors
    Karabulut, Buse
    Uslu, Esra
    [J]. ARCHIVES OF PSYCHIATRIC NURSING, 2024, 49 : 47 - 54
  • [27] Factors of medication non adherence in schizophrenia
    Hajji, K.
    Khouadja, S.
    Zarrouk, L.
    Marrag, I.
    Younes, S.
    Nasr, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S483 - S483
  • [28] Strategies for optimizing medication adherence in schizophrenia
    Morrissette, Debbi A.
    Cutler, Andrew J.
    [J]. CNS SPECTRUMS, 2012, 17 (01) : 31 - 33
  • [29] Antipsychotic polypharmacy patterns and antipsychotic psychiatric medication adherence in patients with schizophrenia
    Joe, Soohyun
    Ahn, Joonho
    Choi, Youngmin
    Lee, JungSun
    Park, Jangho
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 192 - 193
  • [30] Effects of medication adherence on hospitalizations and healthcare costs in patients with schizophrenia in Thailand
    Dilokthornsakul, Piyameth
    Thoopputra, Thitaporn
    Patanaprateep, Oraluck
    Kongsakon, Ronnachai
    Chaiyakunapruk, Nathorn
    [J]. SAGE OPEN MEDICINE, 2016, 4